Pennsylvania

University of Pittsburgh to launch Moderna Clinic Trial for Kids

Vaccine deployment in most Americans continues so slowly that clinical trials in other groups excluded from the initial study have begun. One of those groups is children. Beginning in March, clinical trials of the Moderna COVID-19 vaccine will begin in children aged 6 months to 12 years. The University of Pittsburgh Vaccine Testing Unit is held in many parts of the world. participate. “This will take some time and each site will contribute to a certain number of patients,” said Dr. Amish Adalja, an infectious disease and emergency physician. “We start getting some data about these individuals and see how well they worked in terms of safety, efficacy and dosing schedule. All of them take time to accumulate. Dr. Adalja, an infectious disease expert, believes that. By the time the vaccine is approved for children and teens, it will be summer. At that point, supply is expected to increase significantly. Adalja said the virus was generally excluded from the first study because it has less serious effects on children. “The priority was to get data on adults, especially the elderly, who are likely to suffer from the serious consequences of the virus,” he said. .Adalja. Six-month-old vaccinations may appear very young, but without data, it is unclear how to proceed with vaccinations in this age group, so it is possible to include babies in the study. It’s important, says Dr. Adalja. Do older people need boosters or do they need to lose weight when talking about vaccinations for babies and adolescents? I think everything will be clear. But the basis for all these decisions is data. Dr. Adalja is now able to enroll any family member who is interested in participating.

Vaccine deployment in most Americans continues so slowly that clinical trials in other groups excluded from the initial study have begun. One of those groups is children.

Beginning in March, clinical trials of the Moderna COVID-19 vaccine will begin in children aged 6 months to 12 years.

The University of Pittsburgh Vaccine Trial Unit is one of the local sites where many people from all over the world participate.

“This will take some time and each site will contribute to a certain number of patients,” said Dr. Amish Adalja, an infectious disease and emergency physician. “We start getting some data about these individuals and see how well they worked in terms of safety, efficacy and dosing schedule. It takes a while for all of them to accumulate. I will. “

Infectious disease expert Dr. Adalja believes it will be summer by the time vaccines for children and teenagers are approved. At that point, supply is expected to increase significantly.

Dr. Adalja says the virus was generally excluded from the first study because it has less serious effects on children.

“The priority was to obtain data on adults, especially the elderly, who are likely to suffer from the serious consequences of this virus,” said Dr. Adalja.

Six-month-old vaccinations may appear very young, but without data, it is unclear how to proceed with vaccinations in this age group, so it is possible to include babies in the study. It’s important, says Dr. Adalja.

“May be young, may be old, need boosters, or do we need to lose weight when talking about vaccinations for babies and adolescents? I think it’s all clear. But the rationale is that all these decisions are data, “says Dr. Adalja.

Any family member who is interested in participating can register.

University of Pittsburgh to launch Moderna Clinic Trial for Kids

Source link University of Pittsburgh to launch Moderna Clinic Trial for Kids

Related Articles

Back to top button